-
1
-
-
19344364880
-
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials
-
Early Breast Cancer Trialists' Collaborative Group EBCTCG
-
Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: An overview of the randomised trials. Lancet 365:1687-1717, 2005
-
(2005)
Lancet
, vol.365
, pp. 1687-1717
-
-
-
2
-
-
11444251764
-
Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer
-
Howell A, Cuzick J, Baum M, et al: Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer. Lancet 365:60-62, 2005
-
(2005)
Lancet
, vol.365
, pp. 60-62
-
-
Howell, A.1
Cuzick, J.2
Baum, M.3
-
3
-
-
10744223655
-
A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer
-
Coombes RC, Hall E, Gibson LJ, et al: A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer. N Engl J Med 350:1081-1092, 2004
-
(2004)
N Engl J Med
, vol.350
, pp. 1081-1092
-
-
Coombes, R.C.1
Hall, E.2
Gibson, L.J.3
-
4
-
-
24644519961
-
Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole Trial
-
Boccardo F, Rubagotti A, Puntoni M, et al: Switching to anastrozole versus continued tamoxifen treatment of early breast cancer: Preliminary results of the Italian Tamoxifen Anastrozole Trial. J Clin Oncol 23:5138-5147, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 5138-5147
-
-
Boccardo, F.1
Rubagotti, A.2
Puntoni, M.3
-
5
-
-
23444446523
-
Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial
-
Jakesz R, Jonat W, Gnant M, et al: Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: Combined results of ABCSG trial 8 and ARNO 95 trial. Lancet 366:455-462, 2005
-
(2005)
Lancet
, vol.366
, pp. 455-462
-
-
Jakesz, R.1
Jonat, W.2
Gnant, M.3
-
6
-
-
29544433211
-
A comparison of letrozole and tamoxifen in post-menopausal women with early breast cancer
-
Thürlimann B, Keshaviah A, Coates AS, et al: A comparison of letrozole and tamoxifen in post-menopausal women with early breast cancer. N Engl J Med 353:2747-2757, 2005
-
(2005)
N Engl J Med
, vol.353
, pp. 2747-2757
-
-
Thürlimann, B.1
Keshaviah, A.2
Coates, A.S.3
-
7
-
-
24744450378
-
Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA 17
-
Goss PE, Ingle JN, Martino S, et al: Randomized trial of letrozole following tamoxifen as extended adjuvant therapy in receptor-positive breast cancer: Updated findings from NCIC CTG MA 17. J Natl Cancer Inst 97:1262-1271, 2005
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1262-1271
-
-
Goss, P.E.1
Ingle, J.N.2
Martino, S.3
-
8
-
-
20044382779
-
American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status
-
Winer EP, Hudis C, Burstein HJ, et al: American Society of Clinical Oncology technology assessment on the use of aromatase inhibitors as adjuvant therapy for postmenopausal women with hormone receptor-positive breast cancer: Status report 2004. J Clin Oncol 23:619-629, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 619-629
-
-
Winer, E.P.1
Hudis, C.2
Burstein, H.J.3
-
9
-
-
25844449130
-
Adherence beliefs among breast cancer patients taking tamoxifen
-
Grunfeld EA, Hunter MS, Sikka P, et al: Adherence beliefs among breast cancer patients taking tamoxifen. Patient Educ Couns 59:97-102, 2005
-
(2005)
Patient Educ Couns
, vol.59
, pp. 97-102
-
-
Grunfeld, E.A.1
Hunter, M.S.2
Sikka, P.3
-
10
-
-
4344667475
-
Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer
-
Fink AK, Gurwitz J, Rakowski W, et al: Patient beliefs and tamoxifen discontinuance in older women with estrogen receptor-positive breast cancer. J Clin Oncol 22:3309-3315, 2004
-
(2004)
J Clin Oncol
, vol.22
, pp. 3309-3315
-
-
Fink, A.K.1
Gurwitz, J.2
Rakowski, W.3
-
11
-
-
0036847257
-
Tamoxifen non-compliance: Does it matter?
-
Murthy V, Bharia G, Sarin R: Tamoxifen non-compliance: Does it matter? Lancet Oncol 3:654, 2002
-
(2002)
Lancet Oncol
, vol.3
, pp. 654
-
-
Murthy, V.1
Bharia, G.2
Sarin, R.3
-
12
-
-
0035863386
-
Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women
-
Demissie S, Silliman RA, Lash TL: Adjuvant tamoxifen: Predictors of use, side effects, and discontinuation in older women. J Clin Oncol 19:322-328, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 322-328
-
-
Demissie, S.1
Silliman, R.A.2
Lash, T.L.3
-
13
-
-
0027229141
-
Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring
-
Waterhouse DM, Calzone KA, Mele C, et al: Adherence to oral tamoxifen: A comparison of patient self-report, pill counts, and microelectronic monitoring. J Clin Oncol 11:1189-1197, 1993
-
(1993)
J Clin Oncol
, vol.11
, pp. 1189-1197
-
-
Waterhouse, D.M.1
Calzone, K.A.2
Mele, C.3
-
15
-
-
39149107837
-
Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer
-
Owusu C, Buist DS, Field TS, et al: Predictors of tamoxifen discontinuation among older women with estrogen receptor-positive breast cancer. J Clin Oncol 26:549-555, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 549-555
-
-
Owusu, C.1
Buist, D.S.2
Field, T.S.3
-
16
-
-
0037441639
-
Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer
-
Partridge AH, Wang PS, Winer EP, et al: Nonadherence to adjuvant tamoxifen therapy in women with primary breast cancer. J Clin Oncol 21:602-606, 2003
-
(2003)
J Clin Oncol
, vol.21
, pp. 602-606
-
-
Partridge, A.H.1
Wang, P.S.2
Winer, E.P.3
-
17
-
-
39149111976
-
Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer
-
Partridge AH, Lafountain A, Mayer E, et al: Adherence to initial adjuvant anastrozole therapy among women with early-stage breast cancer. J Clin Oncol 26:556-562, 2008
-
(2008)
J Clin Oncol
, vol.26
, pp. 556-562
-
-
Partridge, A.H.1
Lafountain, A.2
Mayer, E.3
-
18
-
-
79953092632
-
Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer
-
San Francisco, CA, September 7-8, abstr 130
-
Thompson AM, Dewar J, Fahey T, et al: Association of poor adherence to prescribed tamoxifen with risk of death from breast cancer. 2007 Breast Cancer Symposium, San Francisco, CA, September 7-8, 2007 (abstr 130)
-
(2007)
2007 Breast Cancer Symposium
-
-
Thompson, A.M.1
Dewar, J.2
Fahey, T.3
-
19
-
-
0027183973
-
The relation between health insurance coverage and clinical outcomes among women with breast cancer
-
Ayanian JZ, Kohler BA, Abe T, et al: The relation between health insurance coverage and clinical outcomes among women with breast cancer. N Engl J Med 329:326-331, 1993
-
(1993)
N Engl J Med
, vol.329
, pp. 326-331
-
-
Ayanian, J.Z.1
Kohler, B.A.2
Abe, T.3
-
20
-
-
0020064967
-
Race and socioeconomic status in survival from breast cancer
-
Dayal HH, Power RN, Chiu C: Race and socioeconomic status in survival from breast cancer. J Chronic Dis 35:675-683, 1982
-
(1982)
J Chronic Dis
, vol.35
, pp. 675-683
-
-
Dayal, H.H.1
Power, R.N.2
Chiu, C.3
-
21
-
-
0030999351
-
Recent trends in breast cancer mortality among white and black US women
-
Chevarley F, White E: Recent trends in breast cancer mortality among white and black US women. Am J Public Health 87:775-781, 1997
-
(1997)
Am J Public Health
, vol.87
, pp. 775-781
-
-
Chevarley, F.1
White, E.2
-
22
-
-
0032750175
-
Survival differences in breast cancer among racial/ ethnic groups: A population-based study
-
Boyer-Chammard A, Taylor TH, Anton-Culver H: Survival differences in breast cancer among racial/ ethnic groups: A population-based study. Cancer Detect Prev 23:463-473, 1999
-
(1999)
Cancer Detect Prev
, vol.23
, pp. 463-473
-
-
Boyer-Chammard, A.1
Taylor, T.H.2
Anton-Culver, H.3
-
23
-
-
0142248897
-
Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality?
-
Yabroff KR, Gordis L: Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality? Soc Sci Med 57:2265-2279, 2003
-
(2003)
Soc Sci Med
, vol.57
, pp. 2265-2279
-
-
Yabroff, K.R.1
Gordis, L.2
-
24
-
-
0027424291
-
Race, income, and survival from breast cancer at two public hospitals
-
Ansell D, Whitman S, Lipton R, et al: Race, income, and survival from breast cancer at two public hospitals. Cancer 72:2974-2978, 1993
-
(1993)
Cancer
, vol.72
, pp. 2974-2978
-
-
Ansell, D.1
Whitman, S.2
Lipton, R.3
-
25
-
-
0023013743
-
Social class and black-white differences in breast cancer survival
-
Bassett MT, Krieger N: Social class and black-white differences in breast cancer survival. Am J Public Health 76:1400-1403, 1986
-
(1986)
Am J Public Health
, vol.76
, pp. 1400-1403
-
-
Bassett, M.T.1
Krieger, N.2
-
26
-
-
84942479462
-
Treatment differences and other prognostic factors related to breast cancer survival: Delivery systems and medical outcomes
-
Lee-Feldstein A, Anton-Culver H, Feldstein PJ: Treatment differences and other prognostic factors related to breast cancer survival: Delivery systems and medical outcomes. JAMA 271:1163-1168, 1994
-
(1994)
JAMA
, vol.271
, pp. 1163-1168
-
-
Lee-Feldstein, A.1
Anton-Culver, H.2
Feldstein, P.J.3
-
27
-
-
0034667985
-
The effect of less than definitive care on breast carcinoma recurrence and mortality
-
Lash TL, Silliman RA, Guadagnoli E, et al: The effect of less than definitive care on breast carcinoma recurrence and mortality. Cancer 89:1739-1747, 2000
-
(2000)
Cancer
, vol.89
, pp. 1739-1747
-
-
Lash, T.L.1
Silliman, R.A.2
Guadagnoli, E.3
-
28
-
-
37249061682
-
Mortality impact of less-than-standard therapy in older breast cancer patients
-
Yood MU, Owusu C, Buist DS, et al: Mortality impact of less-than-standard therapy in older breast cancer patients. J Am Coll Surg 206:66-75, 2008
-
(2008)
J Am Coll Surg
, vol.206
, pp. 66-75
-
-
Yood, M.U.1
Owusu, C.2
Buist, D.S.3
-
29
-
-
75749093171
-
-
Wikipedia contributors: Medicaid. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/wiki/ Medicaid
-
Wikipedia contributors: Medicaid. Wikipedia, The Free Encyclopedia. http://en.wikipedia.org/wiki/ Medicaid
-
-
-
-
30
-
-
75749130483
-
Patterns of care among breast cancer patients with financial need: Information from a Medicaid-claims and tumor registry linked database
-
suppl; abstr 6037, 537s
-
Kimmick GG, Camacho F, Balkrishnan R, et al: Patterns of care among breast cancer patients with financial need: Information from a Medicaid-claims and tumor registry linked database. J Clin Oncol 23:537s, 2005 (suppl; abstr 6037)
-
(2005)
J Clin Oncol
, vol.23
-
-
Kimmick, G.G.1
Camacho, F.2
Balkrishnan, R.3
-
31
-
-
53649101821
-
Racial differences in patterns of care among medicaidenrolled breast cancer patients
-
Kimmick G, Camacho F, Foley KL, et al: Racial differences in patterns of care among medicaidenrolled breast cancer patients. J Oncol Pract 2:205-213, 2006
-
(2006)
J Oncol Pract
, vol.2
, pp. 205-213
-
-
Kimmick, G.1
Camacho, F.2
Foley, K.L.3
-
32
-
-
33846328685
-
Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy
-
Foley KL, Kimmick G, Camacho F, et al: Survival disadvantage among Medicaid-insured breast cancer patients treated with breast conserving surgery without radiation therapy. Breast Cancer Res Treat 101:207-214, 2007
-
(2007)
Breast Cancer Res Treat
, vol.101
, pp. 207-214
-
-
Foley, K.L.1
Kimmick, G.2
Camacho, F.3
-
33
-
-
75749137109
-
Use of cancer registry data for research on patterns of breast cancer care of individuals with Medicaid insurance
-
suppl; abstr 6021, 533s
-
Anderson RT, Camacho FT, Balkrishnan R, et al: Use of cancer registry data for research on patterns of breast cancer care of individuals with Medicaid insurance. J Clin Oncol 24:533s, 2005 (suppl; abstr 6021)
-
(2005)
J Clin Oncol
, vol.24
-
-
Anderson, R.T.1
Camacho, F.T.2
Balkrishnan, R.3
-
35
-
-
0024060815
-
A general method of compliance assessment using centralized pharmacy records: Description and validation
-
Steiner JF, Koepsell TD, Fihn SD, et al: A general method of compliance assessment using centralized pharmacy records: Description and validation. Med Care 26:814-823, 1988
-
(1988)
Med Care
, vol.26
, pp. 814-823
-
-
Steiner, J.F.1
Koepsell, T.D.2
Fihn, S.D.3
-
36
-
-
0031046049
-
The assessment of refill compliance using pharmacy records: Methods, validity, and applications
-
Steiner JF, Prochazka AV: The assessment of refill compliance using pharmacy records: Methods, validity, and applications. J Clin Epidemiol 50:105-116, 1997
-
(1997)
J Clin Epidemiol
, vol.50
, pp. 105-116
-
-
Steiner, J.F.1
Prochazka, A.V.2
-
37
-
-
22544468809
-
Estimating medication persistency using administrative claims data
-
Sikka R, Xia F, Aubert RE: Estimating medication persistency using administrative claims data. Am J Manag Care 11:449-457, 2005
-
(2005)
Am J Manag Care
, vol.11
, pp. 449-457
-
-
Sikka, R.1
Xia, F.2
Aubert, R.E.3
-
38
-
-
33748343357
-
Methods for evaluation of medication adherence and persistence using automated databases
-
discussion 575-577
-
Andrade SE, Kahler KH, Frech F, et al: Methods for evaluation of medication adherence and persistence using automated databases. Pharmacoepidemiol Drug Saf 15:565-574, 2006; discussion 575-577
-
Pharmacoepidemiol Drug Saf
, vol.15
, Issue.565-574
, pp. 2006
-
-
Andrade, S.E.1
Kahler, K.H.2
Frech, F.3
-
39
-
-
0036272422
-
Patient compliance and persistence with anti-hyperglycemic therapy: Evaluation of a population of type 2 diabetic patients
-
Dailey G, Kim MS, Lian JF: Patient compliance and persistence with anti-hyperglycemic therapy: Evaluation of a population of type 2 diabetic patients. J Int Med Res 30:71-79, 2002
-
(2002)
J Int Med Res
, vol.30
, pp. 71-79
-
-
Dailey, G.1
Kim, M.S.2
Lian, J.F.3
-
40
-
-
0036677782
-
Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data
-
Dasgupta S, Oates V, Bookhart BK, et al: Population-based persistency rates for topical glaucoma medications measured with pharmacy claims data. Am J Manag Care 8:S255-S261, 2002
-
(2002)
Am J Manag Care
, vol.8
-
-
Dasgupta, S.1
Oates, V.2
Bookhart, B.K.3
-
41
-
-
53649099383
-
-
Jean-Baptiste R, Gebhard IK eds, Springfield, IL, North American Association of Central Cancer Registries
-
Jean-Baptiste R, Gebhard IK (eds): Series IV: Cancer Case Ascertainment: Procedure Guidelines for Cancer Registries. Springfield, IL, North American Association of Central Cancer Registries, 2002
-
(2002)
Series IV: Cancer Case Ascertainment: Procedure Guidelines for Cancer Registries
-
-
-
42
-
-
44649195991
-
-
Johnson CH, Adamo M eds, Bethesda, MD, National Cancer Institute, NIH Publication 07-5581
-
Johnson CH, Adamo M (eds): SEER Program Coding and Staging Manual 2007. Bethesda, MD, National Cancer Institute, NIH Publication 07-5581, 2007
-
(2007)
SEER Program Coding and Staging Manual 2007
-
-
-
43
-
-
0030472186
-
Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases
-
D'Hoore W, Bouckaert A, Telquin C: Practical considerations on the use of the Charlson Comorbidity Index with administrative data bases. J Clin Epidemiol 49:1429-1433, 1996
-
(1996)
J Clin Epidemiol
, vol.49
, pp. 1429-1433
-
-
D'Hoore, W.1
Bouckaert, A.2
Telquin, C.3
-
44
-
-
0037114664
-
Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients
-
Blackman SB, Lash TL, Fink AK, et al: Advanced age and adjuvant tamoxifen prescription in early-stage breast carcinoma patients. Cancer 95: 2465-2472, 2002
-
(2002)
Cancer
, vol.95
, pp. 2465-2472
-
-
Blackman, S.B.1
Lash, T.L.2
Fink, A.K.3
-
45
-
-
4644293320
-
Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997
-
Du XL, Key CR, Osborne C: Community-based assessment of adjuvant hormone therapy in women with breast cancer, 1991-1997. Breast J 10:433-439, 2004
-
(2004)
Breast J
, vol.10
, pp. 433-439
-
-
Du, X.L.1
Key, C.R.2
Osborne, C.3
-
46
-
-
4344707888
-
Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer
-
Fyles AW, McCready DR, Manchul LA, et al: Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351:963-970, 2004
-
(2004)
N Engl J Med
, vol.351
, pp. 963-970
-
-
Fyles, A.W.1
McCready, D.R.2
Manchul, L.A.3
-
47
-
-
10344238569
-
Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor- positive tumors
-
Fisher B, Dignam J, Bryant J, et al: Five versus more than five years of tamoxifen therapy for breast cancer patients with negative lymph nodes and estrogen receptor- positive tumors. J Natl Cancer Inst 88:1529-1542, 1996
-
(1996)
J Natl Cancer Inst
, vol.88
, pp. 1529-1542
-
-
Fisher, B.1
Dignam, J.2
Bryant, J.3
-
48
-
-
0033549344
-
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
-
Fisher B, Dignam J, Wolmark N, et al: Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet 353:1993-2000, 1999
-
(1999)
Lancet
, vol.353
, pp. 1993-2000
-
-
Fisher, B.1
Dignam, J.2
Wolmark, N.3
-
49
-
-
0035865147
-
Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23
-
Fisher B, Anderson S, Tan-Chiu E, et al: Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast cancer: Findings from National Surgical Adjuvant Breast and Bowel Project B-23. J Clin Oncol 19:931-942, 2001
-
(2001)
J Clin Oncol
, vol.19
, pp. 931-942
-
-
Fisher, B.1
Anderson, S.2
Tan-Chiu, E.3
-
50
-
-
0037108675
-
Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less
-
Fisher B, Bryant J, Dignam JJ, et al: Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20:4141-4149, 2002
-
(2002)
J Clin Oncol
, vol.20
, pp. 4141-4149
-
-
Fisher, B.1
Bryant, J.2
Dignam, J.J.3
-
51
-
-
0742272455
-
How well do patients report noncompliance with anti-hypertensive medications? A comparison of self-report versus filled prescriptions
-
Wang PS, Benner JS, Glynn RJ, et al: How well do patients report noncompliance with anti-hypertensive medications? A comparison of self-report versus filled prescriptions. Pharmacoepidemiol Drug Saf 13:11-19, 2004
-
(2004)
Pharmacoepidemiol Drug Saf
, vol.13
, pp. 11-19
-
-
Wang, P.S.1
Benner, J.S.2
Glynn, R.J.3
-
52
-
-
33847373003
-
Early discontinuation of tamoxifen: A lesson for oncologists
-
Barron TI, Connolly R, Bennett K, et al: Early discontinuation of tamoxifen: A lesson for oncologists. Cancer 109:832-839, 2007
-
(2007)
Cancer
, vol.109
, pp. 832-839
-
-
Barron, T.I.1
Connolly, R.2
Bennett, K.3
-
53
-
-
1642365729
-
Social support and patient adherence to medical treatment: A meta-analysis
-
DiMatteo MR: Social support and patient adherence to medical treatment: A meta-analysis. Health Psychol 23:207-218, 2004
-
(2004)
Health Psychol
, vol.23
, pp. 207-218
-
-
DiMatteo, M.R.1
-
54
-
-
29144461772
-
Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews
-
Du XL, Key CR, Dickie L, et al: Information on chemotherapy and hormone therapy from tumor registry had moderate agreement with chart reviews. J Clin Epidemiol 59:53-60, 2006
-
(2006)
J Clin Epidemiol
, vol.59
, pp. 53-60
-
-
Du, X.L.1
Key, C.R.2
Dickie, L.3
-
55
-
-
33644831234
-
Insurance status and the use of guideline therapy in the treatment of selected cancers
-
Harlan LC, Greene AL, Clegg LX, et al: Insurance status and the use of guideline therapy in the treatment of selected cancers. J Clin Oncol 23: 9079-9088, 2005
-
(2005)
J Clin Oncol
, vol.23
, pp. 9079-9088
-
-
Harlan, L.C.1
Greene, A.L.2
Clegg, L.X.3
-
56
-
-
33645729721
-
NCCN Task Force Report: Adjuvant Therapy for Breast Cancer
-
suppl 1
-
Carlson RW, Brown E, Burstein HJ, et al: NCCN Task Force Report: Adjuvant Therapy for Breast Cancer. J Natl Compr Canc Netw 4:S1-S26, 2006 (suppl 1)
-
(2006)
J Natl Compr Canc Netw
, vol.4
-
-
Carlson, R.W.1
Brown, E.2
Burstein, H.J.3
-
57
-
-
0034329443
-
Adjuvant Therapy for Breast Cancer
-
Adjuvant Therapy for Breast Cancer. NIH Consens Statement 17:1, 2000
-
(2000)
NIH Consens Statement
, vol.17
, pp. 1
-
-
-
58
-
-
34547852275
-
Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007
-
Goldhirsch A, Wood WC, Gelber RD, et al: Progress and promise: Highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133-1144, 2007
-
(2007)
Ann Oncol
, vol.18
, pp. 1133-1144
-
-
Goldhirsch, A.1
Wood, W.C.2
Gelber, R.D.3
|